Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients

Exclusion Criteria

• •Chemotherapy within past 4 weeks.
• •Uncontrolled inflammatory disease,axillary temperature≥38℃.
• •Merging other malignant tumor.
• •Pregnancy or nursing status.
• •Participation in another clinical trial with and investigational product within 3 months prior to study entry.
• •Severe diabetes mellitus, or poor blood sugar controller.
• •Allergic disease or allergic constitution. History of protein allergy.
• •History of drug addiction and alcoholism.
• •Hematopoietic stem cell transplantation or organ transplantation.
• •Antibiotics were treated within 72 hours before chemotherapy.
• •Long-term use of hormones or immunosuppressive agents.
• •Severe mental or neurological disease.
• •Chronic disease of severe cardiac, kidney and liver.
• •Other conditions that would be excluded from this study according to doctors'judgment.